[96a5a0]: / output / allTrials / identified / NCT01262560_identified.json

Download this file

450 lines (450 with data), 18.6 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
{
"info": {
"nct_id": "NCT01262560",
"official_title": "Phase II Randomized Trial of Prophylactic Manuka Honey for the Reduction of Chemoradiation Therapy Induced Esophagitis-Related Pain During the Treatment of Lung Cancer",
"inclusion_criteria": "Healthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "",
"miscellaneous_criteria": "DISEASE CHARACTERISTICS:\n\n* Patients being treated with combination chemotherapy (definitive or adjuvant) and radiation therapy once daily for small cell or non-small cell lung cancer (primary population for the trial)\n\n * Patients can receive chemoradiotherapy while on a Radiation Therapy Oncology Group (RTOG) lung trial or while not being on a clinical trial\n * No patients receiving chemoradiotherapy while enrolled on a single institution trial or trials coordinated by other cooperative groups\n* No patients with metastatic disease\n* At least 5 cm of the esophagus must be in the 60 Gy isodose volume in 1.6 to 2.0 Gy fractions\n\nPATIENT CHARACTERISTICS:\n\n* Age 18 and up\n* Able to swallow thick liquids prior to treatment\n* Able to speak English or Spanish in order to complete required forms (verbal completion is adequate)\n* No patients with poorly controlled diabetes\n* No known hypersensitivity to honey\n\nPRIOR CONCURRENT THERAPY:\n\n* See Disease Characteristics\n* No patients who have received prior chemotherapy or radiation therapy\n* No patients receiving more than once daily treatments\n* Therapeutic use of honey other than the Manuka honey provided for this trial is not allowed while patients are on study\n* Patients must also avoid honey-flavored medical products and/or sugary, viscous substances\n* Amifostine is not permitted"
},
"inclusion_lines": [
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "N/A",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [],
"miscellaneous_lines": [
{
"line": "* Patients being treated with combination chemotherapy (definitive or adjuvant) and radiation therapy once daily for small cell or non-small cell lung cancer (primary population for the trial)",
"criterions": [
{
"exact_snippets": "Patients being treated with combination chemotherapy",
"criterion": "combination chemotherapy treatment",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "radiation therapy once daily",
"criterion": "radiation therapy frequency",
"requirements": [
{
"requirement_type": "frequency",
"expected_value": "once daily"
}
]
},
{
"exact_snippets": "small cell or non-small cell lung cancer",
"criterion": "lung cancer type",
"requirements": [
{
"requirement_type": "type",
"expected_value": [
"small cell",
"non-small cell"
]
}
]
}
]
},
{
"line": "* Patients can receive chemoradiotherapy while on a Radiation Therapy Oncology Group (RTOG) lung trial or while not being on a clinical trial",
"criterions": [
{
"exact_snippets": "Patients can receive chemoradiotherapy",
"criterion": "chemoradiotherapy",
"requirements": [
{
"requirement_type": "eligibility",
"expected_value": true
}
]
},
{
"exact_snippets": "while on a Radiation Therapy Oncology Group (RTOG) lung trial",
"criterion": "RTOG lung trial participation",
"requirements": [
{
"requirement_type": "eligibility",
"expected_value": true
}
]
},
{
"exact_snippets": "while not being on a clinical trial",
"criterion": "clinical trial participation",
"requirements": [
{
"requirement_type": "eligibility",
"expected_value": false
}
]
}
]
},
{
"line": "* No patients receiving chemoradiotherapy while enrolled on a single institution trial or trials coordinated by other cooperative groups",
"criterions": [
{
"exact_snippets": "No patients receiving chemoradiotherapy",
"criterion": "chemoradiotherapy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "enrolled on a single institution trial",
"criterion": "enrollment in a single institution trial",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "trials coordinated by other cooperative groups",
"criterion": "enrollment in trials coordinated by other cooperative groups",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* No patients with metastatic disease",
"criterions": [
{
"exact_snippets": "No patients with metastatic disease",
"criterion": "metastatic disease",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* At least 5 cm of the esophagus must be in the 60 Gy isodose volume in 1.6 to 2.0 Gy fractions",
"criterions": [
{
"exact_snippets": "At least 5 cm of the esophagus must be in the 60 Gy isodose volume",
"criterion": "esophagus in 60 Gy isodose volume",
"requirements": [
{
"requirement_type": "length",
"expected_value": {
"operator": ">=",
"value": 5,
"unit": "cm"
}
}
]
},
{
"exact_snippets": "1.6 to 2.0 Gy fractions",
"criterion": "fraction size",
"requirements": [
{
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 1.6,
"unit": "Gy"
},
{
"operator": "<=",
"value": 2.0,
"unit": "Gy"
}
]
}
}
]
}
]
},
{
"line": "* Age 18 and up",
"criterions": [
{
"exact_snippets": "Age 18 and up",
"criterion": "age",
"requirements": [
{
"requirement_type": "value",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 18,
"unit": "years"
}
]
}
}
]
}
]
},
{
"line": "* Able to swallow thick liquids prior to treatment",
"criterions": [
{
"exact_snippets": "Able to swallow thick liquids",
"criterion": "ability to swallow thick liquids",
"requirements": [
{
"requirement_type": "ability",
"expected_value": true
}
]
}
]
},
{
"line": "* Able to speak English or Spanish in order to complete required forms (verbal completion is adequate)",
"criterions": [
{
"exact_snippets": "Able to speak English or Spanish",
"criterion": "language proficiency",
"requirements": [
{
"requirement_type": "languages",
"expected_value": [
"English",
"Spanish"
]
}
]
},
{
"exact_snippets": "complete required forms (verbal completion is adequate)",
"criterion": "form completion ability",
"requirements": [
{
"requirement_type": "method",
"expected_value": "verbal"
}
]
}
]
},
{
"line": "* No patients with poorly controlled diabetes",
"criterions": [
{
"exact_snippets": "No patients with poorly controlled diabetes",
"criterion": "diabetes",
"requirements": [
{
"requirement_type": "control",
"expected_value": "not poorly controlled"
}
]
}
]
},
{
"line": "* No known hypersensitivity to honey",
"criterions": [
{
"exact_snippets": "No known hypersensitivity to honey",
"criterion": "hypersensitivity to honey",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "PRIOR CONCURRENT THERAPY:",
"criterions": [
{
"exact_snippets": "PRIOR CONCURRENT THERAPY",
"criterion": "prior concurrent therapy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* See Disease Characteristics",
"criterions": [
{
"exact_snippets": "Disease Characteristics",
"criterion": "disease characteristics",
"requirements": [
{
"requirement_type": "N/A",
"expected_value": "See Disease Characteristics"
}
]
}
]
},
{
"line": "* No patients who have received prior chemotherapy or radiation therapy",
"criterions": [
{
"exact_snippets": "No patients who have received prior chemotherapy",
"criterion": "prior chemotherapy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "No patients who have received prior ... radiation therapy",
"criterion": "prior radiation therapy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* No patients receiving more than once daily treatments",
"criterions": [
{
"exact_snippets": "No patients receiving more than once daily treatments",
"criterion": "treatment frequency",
"requirements": [
{
"requirement_type": "frequency",
"expected_value": {
"operator": "<=",
"value": 1,
"unit": "times per day"
}
}
]
}
]
},
{
"line": "* Therapeutic use of honey other than the Manuka honey provided for this trial is not allowed while patients are on study",
"criterions": [
{
"exact_snippets": "Therapeutic use of honey other than the Manuka honey provided for this trial is not allowed",
"criterion": "therapeutic use of honey",
"requirements": [
{
"requirement_type": "type",
"expected_value": "Manuka honey provided for this trial"
}
]
}
]
},
{
"line": "* Patients must also avoid honey-flavored medical products and/or sugary, viscous substances",
"criterions": [
{
"exact_snippets": "avoid honey-flavored medical products",
"criterion": "honey-flavored medical products",
"requirements": [
{
"requirement_type": "avoidance",
"expected_value": true
}
]
},
{
"exact_snippets": "avoid ... sugary, viscous substances",
"criterion": "sugary, viscous substances",
"requirements": [
{
"requirement_type": "avoidance",
"expected_value": true
}
]
}
]
},
{
"line": "* Amifostine is not permitted",
"criterions": [
{
"exact_snippets": "Amifostine is not permitted",
"criterion": "Amifostine",
"requirements": [
{
"requirement_type": "permitted",
"expected_value": false
}
]
}
]
}
],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": [
{
"line": "DISEASE CHARACTERISTICS:",
"criterions": []
},
{
"line": "PATIENT CHARACTERISTICS:",
"criterions": []
}
]
}